Competition Law and director disqualification for up to 15 years

The first six months of 2019 have provided several interesting headlines as director disqualification starts to wield greater influence in the world of competition law. What is director disqualification? Disqualification orders (by the court) or disqualification undertakings (agreed by the director) are perhaps more commonly known as being imposed upon

Share our insights
Continue reading
Google fined

The Commission Fines Google for a Third Time: A Turning Point for Competition Enforcement and Digital Platforms?

The European Commission has fined Google €1.49 billion ($1.69 billion) for “abusive practices in online advertising.” That is in addition to the $5 billion and $2.4 billion fines it handed to Google in 2018 and 2017 for other anti-competitive practices. Competition commissioner Margrethe Vestager said Google “shielded itself from competitive pressure” via exclusive advertising

Share our insights
Continue reading

CMA’s latest Guidance on Requests for Internal Documents in Merger Investigations

While investigating a merger, the Competition & Markets Authority (‘CMA’) has often requested the merging parties to provide their internal documents, that is, those documents generated internally by an organisation during the ordinary course of its business. These internal documents can include study reports, presentations, emails, hand-written notes etc., irrespective

Share our insights
Continue reading
Sewage farm and water works

The Creation of a “Super-Regulator” for the Utilities Sector: Moving the Deck Chairs?

Following the Autumn 2018 Budget, the Government has recently launched a consultation on how to encourage greater innovation in the utilities sectors. Amongst those measures is a review by the National Infrastructure Committee (NIC) into the operation of UK regulators and the potential establishment of a multi-sector “super-regulator” for utilities.

Share our insights
Continue reading
Medical cannabis

Medical cannabis – the evolving law and innovation in treatment

The developing legal approach in the UK to medical cannabis highlights the problems law makers have in responding adequately to clinical and technological advances: especially those that challenge conventional views. This has arguably stifled innovation in medical cannabis research in the UK, and prevented patients from receiving worthwhile treatments. This

Share our insights
Continue reading